The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences.
OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B
Related Posts
NTT DATA and NVIDIA bring enterprise AI factories to production scale
NTT DATA has announced an initiative to deliver NVIDIA-powered platforms designed to give organisations a repeatable, production-ready model…
Anthropic, Blackstone bet the next trillion-dollar AI business is implementation, not models
Anthropic-backed Ode launches as AI labs bet that embedding forward-deployed engineers inside enterprises is the key to accelerating…
Google’s Gemini nears billion-user milestone
Gemini had over 750 million monthly users in February.
